Global Head Lice Infestation Treatment Market Size, Share and Trends Analysis Report, By Type (Lotion, Creams, Shampoo, Others), By Application (Children, Adult), Forecast (2022-2028)

The global head lice infestation treatment market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). A major factor contributing to market growth is the increase in the number of people affected by lice, especially among school children. Symptoms of head lice include severe scalp itching, feeling like something is crawling on the scalp, and sores and scabies on your skin due to itching. There are many treatment options for removing head lice, but most treatments will need to be used twice or more. The second treatment was a week later to kill all four newly hatched nits. The FDA approved includes ivermectin lotion, which does not kill eggs, malathion lotion that kills lice and live eggs, spinosad that also kills lice and live eggs, and finally Benzyl alcohol – which only kills live lice.

High levels of pollution and the level of lice infection and the lack of awareness about personal hygiene are driving the demand for lice treatment in the developing world. The increase in the cost of health care and the increase in market access for athletes can be attributed to the growing market for lice-infested drugs. Increasing numbers of children prone to lice infestations are expected to increase the demand for the global head lice-infested drug market. Easy availability of chemicals used to remove head lice such as Pyrethrin and Benzyl alcohol lotion is expected to grow in a market infested with head lice. The high cost of health care is one of the limitations in this market. There is a chance that lice will recur, which reduces consumers’ spending more money on treatment.

Some major players in the market include Arborpharma, BayerAG, Omega Pharma, Major Pharmaceuticals, and Shionogi, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in October 2020, FDA approved nonprescription Sklice (ivermectin) lotion, 0.5% for the topical treatment of the head lice infestations in patients 6 months of age and older to Arbor Pharmaceuticals LLC.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Arborpharma, BayerAG, Omega Pharma, Major Pharmaceuticals, and Shionogi, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Head Lice Infestation Treatment Market Report by Segment

By Type

• Lotion
• Cream
• Shampoo
• Others

By Application

• Children
• Adult

Global Head Lice Infestation Treatment Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa